Posted By Coherent Market Insights
Posted on September 29, 2021
Anti-Fungal Drugs Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Anti-Fungal Drugs Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/237
Note: *The Sample only consist of Table of Content (ToC), Research Framework of the actual report, and Research Methodology adopted for it.
Major Players In This Market Are: SCYNEXIS, Inc
An antifungal medication also antimycotic medication is a pharmaceutical fungicide or fungistatic used to prevent or treat mycosis such as ringworm, athlete’s foot, candidiasis, or severe systematic infections. Common fungal infections such as fungal nail infection, vaginal infection, and ringworm usually occur on the external surface of the body, while certain fungal invasive infections occur inside the tissue of body or in an internal organ such as lungs and brain. Generally, fungal infection is associated with a weak immune system, with people suffering from HIV and AIDS, and those undergoing high dosage chemotherapy more susceptible to invasive fungal infections. Antifungal drugs work against fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.
According to the Centers for Disease Control and Prevention (CDC), around 1 million people get infected worldwide by cryptococcal meningitis, which is a brain infection caused by fungus Cryptococcus and it subsequently leads to 625,000 deaths. These cases are mainly reported in sub-Saharan Africa. Moreover, the histoplasmosis infection mostly occurs in the U.S. and some portion of Central and South America. According to the same source, the histoplasmosis is a common infection observed in people with HIV and AIDS. In case of histoplasmosis, late diagnosis and treatment can be fatal.
The global antifungal drugs market recorded double-digit Y-o-Y growth in 2016 and it is expected witness steady growth rate in the near future. This growth is attributed to increasing prevalence of infections and changing climatic conditions, in turn increasing incidence of fungal infections. Moreover, Latin and South America have witnessed more growth in anti-fungal drugs revenue than North America in the recent past.
Increasing accessibility to low-cost over-the-counter (OTC) antifungal drugs creates a highly lucrative environment for growth of the global antifungal drugs market.
Global antifungal drugs market taxonomy:
By Drug Type
-
Azoles
-
Echinocandins
-
Allylamines
-
Polyenes
-
Others
By Therapeutic Indication
-
Dermatophytosis
-
Candidiasis
-
Other therapeutic indications
By Geography
-
North America
-
Latin America
-
Europe
-
Middle East
-
APAC
-
Africa
Market Dynamics
Growing incidence of antifungal infections and increasing popularity of OTC drugs to drive growth of the global antifungal drugs market in near the future
Increasing incidence of antifungal infections worldwide is expected to drive growth of the global antifungal drugs market during the forecast period. Changing environment conditions and increasing pollution has led to increasing prevalence of various infections. Moreover, exponential growth of population is expected to boost the demand for antifungal drugs in the near future.
However, presence of counterfeit drugs in different regions around the world is expected to restrain growth of the global antifungal drugs market in the near future.
Regional Insights
Among regions, North America accounts for the largest market share in the global antifungal drugs market. This is owing increasing awareness regarding infections and high investment in R&D in the region. Furthermore, emerging economies in Asia Pacific region are expected to exhibit high growth rate over the forecast period, owing to increasing awareness regarding infectious diseases, increasing number of R&D activities, and growing target population.
Moreover, growing popularity of OTC drugs in the region, as they are cost effective for the patients and growing advertisement of antifungal drugs for dermal infections such as for skin infection is expected to propel the global antifungal drugs market over the forecast period. Furthermore, patent expiration of branded drugs will drive the market growth. Increased funding for R&D in developed countries and increased focus on product innovation will further augment market growth.
Key Developments
-
Major companies in the market are involved in various growth strategies such as collaboration and agreement, in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution of Beasilea’s antifungal treatments. Pfizer will manufacture and distribute drugs for treatment of life-threatening invasive mold infections in Russia, Israel, Europe (excluding Nordics), and Turkey.
-
Key players in the market are adopting various business strategies such as research and development, in order to expand their product portfolio. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from first interim efficiency analysis of ongoing FURI study. The development of this novel treatment is indicated for fungal treatment.
-
Key players in the market are focused on various growth strategies such as gaining product approval from regulatory authorities, in order to strengthen their market presence. For instance, in February 2018, Insmed, Inc., a biopharmaceutical company, received the U.S. Food and Drugs Administration (FDA) approval for new drug Arikayce (amikacin liposome inhalation suspension), which was approved limited population pathway for antibacterial and antifungal drugs program.
Buy This Premium Report Of Anti-Fungal Drugs Market Report 2021 With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/237
In this study, the years considered to estimate the market size of Anti-Fungal Drugs are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Anti-Fungal Drugs Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Anti-Fungal Drugs Market are also given.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Anti-Fungal Drugs Market Size Is Projected to Grow at a CAGR of 3.1% By 2027 | Future Growth Insights, Share Value, Trends and Dynamics appeared first on Gatorledger.
Anti-Fungal Drugs Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Anti-Fungal Drugs Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/237
Note: *The Sample only consist of Table of Content (ToC), Research Framework of the actual report, and Research Methodology adopted for it.
Major Players In This Market Are: SCYNEXIS, Inc
An antifungal medication also antimycotic medication is a pharmaceutical fungicide or fungistatic used to prevent or treat mycosis such as ringworm, athlete’s foot, candidiasis, or severe systematic infections. Common fungal infections such as fungal nail infection, vaginal infection, and ringworm usually occur on the external surface of the body, while certain fungal invasive infections occur inside the tissue of body or in an internal organ such as lungs and brain. Generally, fungal infection is associated with a weak immune system, with people suffering from HIV and AIDS, and those undergoing high dosage chemotherapy more susceptible to invasive fungal infections. Antifungal drugs work against fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.
According to the Centers for Disease Control and Prevention (CDC), around 1 million people get infected worldwide by cryptococcal meningitis, which is a brain infection caused by fungus Cryptococcus and it subsequently leads to 625,000 deaths. These cases are mainly reported in sub-Saharan Africa. Moreover, the histoplasmosis infection mostly occurs in the U.S. and some portion of Central and South America. According to the same source, the histoplasmosis is a common infection observed in people with HIV and AIDS. In case of histoplasmosis, late diagnosis and treatment can be fatal.
The global antifungal drugs market recorded double-digit Y-o-Y growth in 2016 and it is expected witness steady growth rate in the near future. This growth is attributed to increasing prevalence of infections and changing climatic conditions, in turn increasing incidence of fungal infections. Moreover, Latin and South America have witnessed more growth in anti-fungal drugs revenue than North America in the recent past.
Increasing accessibility to low-cost over-the-counter (OTC) antifungal drugs creates a highly lucrative environment for growth of the global antifungal drugs market.
Global antifungal drugs market taxonomy:
By Drug Type
Azoles
Echinocandins
Allylamines
Polyenes
Others
By Therapeutic Indication
Dermatophytosis
Candidiasis
Other therapeutic indications
By Geography
North America
Latin America
Europe
Middle East
APAC
Africa
Market Dynamics
Growing incidence of antifungal infections and increasing popularity of OTC drugs to drive growth of the global antifungal drugs market in near the future
Increasing incidence of antifungal infections worldwide is expected to drive growth of the global antifungal drugs market during the forecast period. Changing environment conditions and increasing pollution has led to increasing prevalence of various infections. Moreover, exponential growth of population is expected to boost the demand for antifungal drugs in the near future.
However, presence of counterfeit drugs in different regions around the world is expected to restrain growth of the global antifungal drugs market in the near future.
Regional Insights
Among regions, North America accounts for the largest market share in the global antifungal drugs market. This is owing increasing awareness regarding infections and high investment in R&D in the region. Furthermore, emerging economies in Asia Pacific region are expected to exhibit high growth rate over the forecast period, owing to increasing awareness regarding infectious diseases, increasing number of R&D activities, and growing target population.
Moreover, growing popularity of OTC drugs in the region, as they are cost effective for the patients and growing advertisement of antifungal drugs for dermal infections such as for skin infection is expected to propel the global antifungal drugs market over the forecast period. Furthermore, patent expiration of branded drugs will drive the market growth. Increased funding for R&D in developed countries and increased focus on product innovation will further augment market growth.
Key Developments
Major companies in the market are involved in various growth strategies such as collaboration and agreement, in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution of Beasilea’s antifungal treatments. Pfizer will manufacture and distribute drugs for treatment of life-threatening invasive mold infections in Russia, Israel, Europe (excluding Nordics), and Turkey.
Key players in the market are adopting various business strategies such as research and development, in order to expand their product portfolio. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from first interim efficiency analysis of ongoing FURI study. The development of this novel treatment is indicated for fungal treatment.
Key players in the market are focused on various growth strategies such as gaining product approval from regulatory authorities, in order to strengthen their market presence. For instance, in February 2018, Insmed, Inc., a biopharmaceutical company, received the U.S. Food and Drugs Administration (FDA) approval for new drug Arikayce (amikacin liposome inhalation suspension), which was approved limited population pathway for antibacterial and antifungal drugs program.
Buy This Premium Report Of Anti-Fungal Drugs Market Report 2021 With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/237
In this study, the years considered to estimate the market size of Anti-Fungal Drugs are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Anti-Fungal Drugs Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Anti-Fungal Drugs Market are also given.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Anti-Fungal Drugs Market Size Is Projected to Grow at a CAGR of 3.1% By 2027 | Future Growth Insights, Share Value, Trends and Dynamics appeared first on Gatorledger.
